GO:0086036 regulation of cardiac muscle cell membrane potential: Electrophysiological Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086036 describes any process that modulates the establishment or extent of the membrane potential in a cardiac muscle cell (cardiomyocyte), the electrical voltage difference across the cardiomyocyte membrane.
• Cardiomyocyte membrane potential is set by the coordinated activity of ion channels, transporters, and gap junctions that carry inward and outward currents during the action potential.
• Calcium handling, including L-type Ca2+ current (ICa,L) and sarcoplasmic reticulum release, is a central determinant of the plateau phase and overall action potential duration in cardiomyocytes.
• Mitochondrial ion channels and metabolic state influence cardiomyocyte excitability and survival, linking membrane potential regulation to ischemic and metabolic stress responses.
• Endogenous transmitter systems, such as glutamatergic signaling, and membrane trafficking of Kv1.5 modulate atrial cardiomyocyte excitability and conductivity, with implications for atrial fibrillation.
• Human iPSC-derived cardiomyocytes provide a tractable model to study maturation-dependent changes in membrane potential regulation and drug responses.
Description
Regulation of cardiac muscle cell membrane potential (GO:0086036) is a biological process that encompasses all mechanisms controlling the electrical voltage across the cardiomyocyte membrane. This voltage, or membrane potential, arises from the unequal distribution of ions across the sarcolemma and is dynamically shaped by ion channels, transporters, and intercellular coupling. Because the cardiac action potential drives excitation-contraction coupling, precise regulation of membrane potential is essential for normal heart rhythm and pump function. Disruption of these regulatory processes can lead to arrhythmias, conduction defects, and contractile dysfunction. Researchers study GO:0086036 to understand how ion channel activity, calcium signaling, metabolic cues, and membrane trafficking converge to set cardiomyocyte excitability. The term is also relevant to disease modeling, drug safety assessment, and the development of cell-based therapies, as human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly used to interrogate these mechanisms. This article synthesizes authoritative GO annotation and published literature to provide a research-grade overview of GO:0086036, its molecular players, and experimental approaches.
regulation of cardiac muscle cell membrane potential At A Glance
| GO ID | GO:0086036 |
|---|---|
| GO term | regulation of cardiac muscle cell membrane potential |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulation of the electrical membrane potential in cardiomyocytes through ion channel, transporter, and signaling activities |
| Related cellular entities | Sarcolemma, ion channels (e.g., voltage-gated Na+, K+, Ca2+ channels), gap junctions, mitochondria |
| Key physiological outcome | Control of action potential duration, resting potential, and excitation-contraction coupling |
| Disease relevance | Arrhythmias, atrial fibrillation, ischemic injury, and cardiomyopathy |
| Model systems | hiPSC-derived cardiomyocytes, primary cardiomyocytes, heterologous expression systems |
What Is GO:0086036?
GO:0086036, regulation of cardiac muscle cell membrane potential, refers to any process that modulates the establishment or extent of the membrane potential in a cardiac muscle cell (a cardiomyocyte). A membrane potential is the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. In practice, this includes the regulation of ion fluxes, channel gating, transporter activity, and electrical coupling that together determine the resting and action potential voltages of cardiomyocytes.
Why Is regulation of cardiac muscle cell membrane potential Important in Cell Biology?
GO:0086036 is fundamental to cardiac physiology because the membrane potential of cardiomyocytes governs excitability, conduction, and the timing of contraction. Dysregulation of this process underlies a wide range of cardiac disorders, including atrial fibrillation, long QT syndromes, and ischemia-reperfusion injury. Understanding the regulatory mechanisms enables the development of targeted therapies and improves the predictive value of preclinical models such as hiPSC-derived cardiomyocytes.
• Membrane potential regulation determines the cardiac action potential waveform and duration, which are critical for coordinated heart contraction.
• It controls the opening and closing of voltage-gated ion channels, thereby influencing calcium influx and excitation-contraction coupling.
• Dysregulation contributes to atrial fibrillation through altered Kv1.5 trafficking and glutamatergic signaling.
• Mitochondrial ion channels and metabolic stress modulate membrane potential and cell survival during ischemia.
• Aging-related changes in ICa,L, such as those mediated by p300/Ahnak1, can depress atrial myocyte function.
• Pharmacological and toxicological responses of cardiomyocytes depend on their membrane potential regulatory state.
• hiPSC-derived cardiomyocytes are a key model for studying human-specific membrane potential regulation and disease.
• Understanding GO:0086036 aids in identifying drug targets for arrhythmias and heart failure.
What Happens During regulation of cardiac muscle cell membrane potential?
Resting Membrane Potential Establishment
In simple terms: The resting membrane potential is the baseline voltage of a heart cell when it is not actively firing.
The resting membrane potential of cardiomyocytes is primarily determined by the permeability to potassium ions through inward rectifier K+ channels and the activity of the Na+/K+-ATPase, which maintains ionic gradients. This negative resting voltage sets the threshold for excitation and influences the availability of voltage-gated sodium and calcium channels.
Action Potential Initiation and Upstroke
In simple terms: When a heart cell is stimulated, sodium channels open briefly, causing a rapid voltage spike.
Depolarization is initiated by the opening of voltage-gated sodium channels, leading to a rapid influx of Na+ and the upstroke of the action potential. This phase is tightly regulated by channel gating properties and membrane lipid composition, and it determines conduction velocity in cardiac tissue.
Plateau Phase and Calcium Handling
In simple terms: The plateau is a sustained high-voltage phase driven by calcium entering the cell, which also triggers contraction.
The plateau phase of the cardiac action potential is maintained by a balance between inward L-type calcium current (ICa,L) and outward potassium currents. Calcium entering through ICa,L triggers sarcoplasmic reticulum calcium release, coupling membrane potential to contraction. Aging and signaling molecules such as p300/Ahnak1 can depress ICa,L, altering the plateau and action potential duration.
Repolarization and Potassium Currents
In simple terms: Repolarization is the process that returns the cell to its resting voltage by letting potassium ions exit.
Repolarization is mediated by various potassium currents, including transient outward (Ito), rapid and slow delayed rectifier (IKr, IKs), and inward rectifier (IK1) currents. The trafficking and surface expression of Kv1.5 channels, regulated by SNAP25-dependent membrane trafficking, critically influence atrial repolarization and the onset of atrial fibrillation.
Modulation by Neurotransmitters and Metabolic Signals
In simple terms: Nerves and metabolic conditions can fine-tune the voltage of heart cells.
An endogenous glutamatergic transmitter system controls the excitability and conductivity of atrial cardiomyocytes, demonstrating that neurotransmitter signaling directly regulates membrane potential. Mitochondrial ion channels and circadian Clock-regulated autophagy also influence cardiomyocyte survival and electrical stability during ischemic stress.
Key Genes Involved in GO:0086036 regulation of cardiac muscle cell membrane potential
The following genes and proteins are central to the regulation of cardiac muscle cell membrane potential (GO:0086036), based on published functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Voltage-gated sodium channel alpha subunit; mediates action potential upstroke | Mutations cause Brugada syndrome and conduction defects; target for antiarrhythmic drugs |
| CACNA1C | L-type calcium channel alpha-1C subunit; carries ICa,L during plateau | Modulated by aging and p300/Ahnak1; key for excitation-contraction coupling |
| KCNA5 | Kv1.5 potassium channel; contributes to atrial repolarization | SNAP25-dependent trafficking regulates atrial fibrillation onset |
| KCNH2 | hERG potassium channel; mediates rapid delayed rectifier current (IKr) | Drug-induced arrhythmia risk; long QT syndrome target |
| KCNQ1 | Slow delayed rectifier potassium channel (IKs) | Long QT syndrome and atrial fibrillation; modulates action potential duration |
| KCNJ2 | Inward rectifier potassium channel Kir2.1; sets resting potential | Andersen-Tawil syndrome; regulation of resting membrane potential |
| SNAP25 | SNARE protein involved in membrane trafficking of Kv1.5 | Regulates atrial cardiomyocyte excitability and fibrillation |
| AHNAK1 | Scaffold protein modulating calcium channel activity | p300/Ahnak1 axis depresses ICa,L in aging atrial myocytes |
| EP300 | Transcriptional coactivator p300; regulates gene expression | Involved in aging-induced ICa,L depression via Ahnak1 |
| CLOCK | Circadian clock transcription factor | Regulates mitochondrial autophagy and survival in cardiac myocytes during ischemia |
| GRIN1 | NMDA receptor subunit; part of glutamatergic signaling | Endogenous glutamatergic system controls atrial excitability |
| GRIN2B | NMDA receptor subunit | Glutamatergic regulation of cardiomyocyte conductivity |
| ATP2A2 | SERCA2a calcium pump; regulates SR calcium load | Indirectly affects membrane potential via calcium-dependent currents |
| RYR2 | Ryanodine receptor 2; SR calcium release channel | Calcium-induced calcium release influences action potential plateau |
| NPPA | Atrial natriuretic peptide; marker of atrial stretch | Associated with atrial fibrillation and electrical remodeling |
| GJA1 | Connexin 43; gap junction protein for electrical coupling | Determines conduction velocity and tissue-level membrane potential synchronization |
| GJA5 | Connexin 40; atrial gap junction protein | Atrial conduction and fibrillation susceptibility |
| KCNE1 | Beta subunit for KCNQ1; modulates IKs | Long QT syndrome and atrial arrhythmia |
How Is regulation of cardiac muscle cell membrane potential Regulated?
The regulation of cardiac muscle cell membrane potential is itself modulated by multiple signaling pathways. The p300/Ahnak1 axis has been shown to depress L-type calcium current (ICa,L) in atrial myocytes during aging, thereby altering action potential characteristics. The circadian Clock gene regulates mitochondrial autophagy and cell survival in cardiac myocytes under ischemic stress, indirectly influencing electrical stability. Mitochondrial ion channels respond to metabolic signals and reactive oxygen species, affecting membrane potential and cell fate. Additionally, SNAP25-dependent membrane trafficking controls the surface expression of Kv1.5 channels, thereby regulating atrial repolarization and the onset of atrial fibrillation. These examples illustrate that GO:0086036 is subject to transcriptional, post-translational, and trafficking-level regulation.
regulation of cardiac muscle cell membrane potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNA5 | Atrial fibrillation; Kv1.5 trafficking | Knockout or point-mutation hiPSC-derived cardiomyocytes |
| CACNA1C | Aging-related ICa,L depression; arrhythmia | Overexpression of Ahnak1 in atrial myocytes |
| CLOCK | Ischemic stress; mitochondrial autophagy | Cardiomyocyte-specific Clock knockout mice |
| GRIN1/GRIN2B | Atrial excitability and conductivity | Glutamatergic signaling knockout models |
| SCN5A | Brugada syndrome; conduction defects | Knock-in mouse models or hiPSC-CMs |
Atrial Fibrillation
Atrial fibrillation is the most common sustained arrhythmia and is strongly associated with dysregulated atrial cardiomyocyte membrane potential. SNAP25-dependent trafficking of Kv1.5 channels regulates the onset of atrial fibrillation, and an endogenous glutamatergic transmitter system controls atrial excitability and conductivity. These findings highlight GO:0086036 as a central node in atrial arrhythmogenesis.
Ischemic Heart Disease and Mitochondrial Dysfunction
During ischemia, mitochondrial ion channels and circadian Clock-regulated autophagy influence cardiomyocyte survival and electrical stability. Mitochondrial ROS-dependent ferroptosis contributes to doxorubicin-induced myocardial damage, linking metabolic stress to membrane potential dysregulation. Thus, GO:0086036 is relevant to ischemic injury and cardiotoxicity.
Aging-Related Electrical Remodeling
Aging is associated with depression of L-type calcium current (ICa,L) in atrial myocytes, mediated in part by the p300/Ahnak1 pathway. This electrical remodeling can predispose to arrhythmias and contractile dysfunction, underscoring the importance of GO:0086036 in age-related cardiac disease.
From regulation of cardiac muscle cell membrane potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KCNA5 alter atrial action potential duration? | KCNA5 knockout hiPSC-derived cardiomyocytes |
| How does Ahnak1 phosphorylation affect ICa,L? | Point-mutation knock-in of AHNAK1 in atrial myocytes |
| Can SNAP25 rescue Kv1.5 trafficking defects? | Overexpression of SNAP25 in cardiomyocytes |
| What is the role of Clock in ischemic membrane potential regulation? | Cardiomyocyte-specific Clock knockout mice |
| Does glutamatergic signaling modulate atrial conduction? | GRIN1/GRIN2B knockout or pharmacological blockade |
| How does metabolic maturation affect membrane potential? | hiPSC-CMs cultured in metabolic maturation media |
How to Study the regulation of cardiac muscle cell membrane potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Ionic currents and action potentials | Characterization of channel function in cardiomyocytes |
| Calcium imaging | Intracellular calcium transients | Excitation-contraction coupling studies |
| Surface biotinylation | Membrane protein trafficking | Kv1.5 surface expression regulated by SNAP25 |
| Western blot | Protein expression levels | Quantification of ion channel subunits |
| qRT-PCR | mRNA expression | Gene expression changes in disease models |
| Voltage-sensitive dyes | Membrane potential changes | High-throughput screening in hiPSC-CMs |
| Mitochondrial ROS assay | Reactive oxygen species | Ferroptosis and metabolic stress studies |
| Autophagy flux assay | Autophagic activity | Clock-regulated survival in cardiac myocytes |
Patch-Clamp Electrophysiology
Patch-clamp recordings measure ionic currents and membrane potential directly in cardiomyocytes, allowing detailed characterization of action potential duration, resting potential, and individual channel contributions. This technique is essential for studying GO:0086036 at the cellular level.
Calcium Imaging
Fluorescent calcium indicators enable real-time monitoring of intracellular calcium transients, which are tightly coupled to membrane potential changes during excitation-contraction coupling. Calcium imaging can reveal how alterations in ICa,L or SR release affect the action potential plateau.
Molecular Biology and Trafficking Assays
Western blotting, co-immunoprecipitation, and surface biotinylation assess the expression and membrane trafficking of ion channels such as Kv1.5, which is regulated by SNAP25. These methods help identify regulatory mechanisms upstream of membrane potential changes.
Genetically Encoded Voltage Indicators
Optogenetic voltage sensors allow non-invasive, high-throughput monitoring of membrane potential dynamics in cardiomyocyte monolayers and hiPSC-derived cardiomyocytes. This approach is useful for drug screening and disease modeling.
How CRISPR Can Be Used to Study GO:0086036 regulation of cardiac muscle cell membrane potential
Knockout
CRISPR knockout of genes such as KCNA5 or GRIN1 in hiPSC-derived cardiomyocytes can reveal their essential roles in regulating membrane potential and action potential duration. Knockout models help distinguish whether a candidate gene is required for normal electrophysiology.
Point Mutation
Introducing disease-associated point mutations (e.g., in SCN5A or KCNH2) via CRISPR allows precise modeling of channelopathies and assessment of how specific residues affect membrane potential regulation. Point-mutation knock-in models are valuable for drug response studies.
Knock-in
Knock-in of reporter tags or human disease alleles (e.g., AHNAK1 variants) enables tracking of protein localization and function in cardiomyocytes. This approach can clarify how regulatory proteins modulate ion channel activity.
Overexpression
CRISPR activation or lentiviral overexpression of genes like SNAP25 or CLOCK can test sufficiency in rescuing or altering membrane potential phenotypes. Overexpression models are useful for gain-of-function studies in GO:0086036 research.
How EDITGENE Supports regulation of cardiac muscle cell membrane potential Research
Researchers studying regulation of cardiac muscle cell membrane potential-related genes often need to determine whether a candidate gene is causally involved in setting or modulating cardiomyocyte excitability. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression, tailored for cardiac cell models.
Contact EDITGENE today to design your custom CRISPR model for regulation of cardiac muscle cell membrane potential research.
Frequently Asked Questions About regulation of cardiac muscle cell membrane potential
What is GO:0086036?
GO:0086036 is the Gene Ontology term for regulation of cardiac muscle cell membrane potential, describing any process that modulates the electrical voltage across a cardiomyocyte membrane.
What genes are involved in regulation of cardiac muscle cell membrane potential?
Key genes include SCN5A, CACNA1C, KCNA5, KCNH2, KCNQ1, KCNJ2, SNAP25, AHNAK1, EP300, CLOCK, GRIN1, and GRIN2B, among others.
How is cardiac muscle cell membrane potential regulated?
It is regulated by the coordinated activity of ion channels, transporters, gap junctions, calcium handling, and signaling pathways such as p300/Ahnak1 and glutamatergic transmission.
Why is membrane potential important in cardiomyocytes?
Membrane potential controls excitability, conduction, and excitation-contraction coupling, and its dysregulation leads to arrhythmias and contractile dysfunction.
What diseases are associated with dysregulated cardiac membrane potential?
Atrial fibrillation, long QT syndrome, Brugada syndrome, ischemic injury, and aging-related electrical remodeling are associated with dysregulated membrane potential.
How can I study GO:0086036 in the lab?
Patch-clamp electrophysiology, calcium imaging, voltage-sensitive dyes, and molecular trafficking assays are commonly used to study membrane potential regulation.
What model systems are used for cardiac membrane potential research?
hiPSC-derived cardiomyocytes, primary cardiomyocytes, and genetically modified mouse models are widely used.
Can CRISPR be used to study cardiac membrane potential genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes regulating membrane potential.
What is the role of SNAP25 in cardiac membrane potential?
SNAP25-dependent membrane trafficking of Kv1.5 channels regulates atrial repolarization and the onset of atrial fibrillation.
How does aging affect cardiac membrane potential?
Aging can depress L-type calcium current (ICa,L) via the p300/Ahnak1 pathway, altering action potential duration in atrial myocytes.
Conclusion
GO:0086036, regulation of cardiac muscle cell membrane potential, is a central biological process that integrates ion channel activity, calcium signaling, metabolic cues, and membrane trafficking to control cardiomyocyte excitability. Its dysregulation is implicated in atrial fibrillation, ischemic injury, and aging-related electrical remodeling. Advances in hiPSC-derived cardiomyocyte models and CRISPR-based gene editing are accelerating the discovery of novel regulatory mechanisms and therapeutic targets. Continued research into this process will improve our understanding of cardiac physiology and disease.
References
- 1. Feyen DAM et al.. 2020. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.. Cell Rep 32(3):107925 PMID: 32697997
- 2. Zhang L et al.. 2025. Kaempferol protects against doxorubicin-induced myocardial damage by inhibiting mitochondrial ROS-dependent ferroptosis.. Redox Rep 30(1):2503130 PMID: 40361284
- 3. Peng DW et al.. 2026. p300/Ahnak1 promotes the depression of I(Ca,L) of atrial myocytes induced by aging.. Biochim Biophys Acta Mol Basis Dis 1872(7):168292 PMID: 42155816
- 4. Rabinovich-Nikitin I et al.. 2021. Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress.. Autophagy 17(11):3794-3812 PMID: 34085589
- 5. Gilbert G et al.. 2020. Calcium Signaling in Cardiomyocyte Function.. Cold Spring Harb Perspect Biol 12(3) PMID: 31308143
- 6. Xie D et al.. 2021. Identification of an endogenous glutamatergic transmitter system controlling excitability and conductivity of atrial cardiomyocytes.. Cell Res 31(9):951-964 PMID: 33824424
- 7. Singh H. 2021. Mitochondrial ion channels in cardiac function.. Am J Physiol Cell Physiol 321(5):C812-C825 PMID: 34550794
- 8. Su X et al.. 2025. SNAP25-dependent membrane trafficking of the Kv1.5 channel regulates the onset of atrial fibrillation.. Nat Commun 16(1):3730 PMID: 40253375
